Orthopedic Surgery Doctors in Flint, MI Accepting Medicare

28 Orthopedic Surgery doctors found. Showing 21 - 28

Travis Baes, Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 401 S Ballenger Hwy, Flint, MI 48532 Phone: 810-342-5656

Dr. James Douglas Ostrander, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4466 W Bristol Rd, Flint, MI 48507 Phone: 810-733-1200    Fax: 810-733-0688

Paul Matthew Telehowski, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4466 W Bristol Rd, Flint, MI 48507 Phone: 810-733-1200    Fax: 810-733-0688

Osy Bosah Ndubaku, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 S Ballenger Hwy, Flint, MI 48532 Phone: 810-342-2111

Joshua Hammond, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 S Ballenger Hwy, Flint, MI 48532 Phone: 810-342-2111

Lucas Mckean, Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 401 S Ballenger Hwy, Flint, MI 48532 Phone: 810-342-5656

Nathanael Adams, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 401 S Ballenger Hwy, Flint, MI 48532 Phone: 810-342-2000

Dr. Matthew Carl Sardelli, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 4466 W Bristol Rd, Flint, MI 48507 Phone: 810-733-1200    Fax: 810-733-0688

News Archive

New inhibitor makes drug-resistant tumor cells respond again to chemotherapy

A new substance could improve the treatment of persistent cancers. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Greifswald have developed a new inhibitor that makes drug-resistant tumour cells respond again to chemotherapy.

Clinical data of dendritic cell based vaccine to be presented at Cancer Stem Cells Conference

ImmunoCellular Therapeutics announced today that Manish Singh, Ph.D., President and CEO, will be presenting at the Cancer Stem Cells Conference, a leading industry event, on Wednesday, March 24th at 2:00 p.m. eastern time.

MacuSight's clinical development update on its proprietary ocular sirolimus product

MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today provided a clinical development update for Perceiva, the company's proprietary ocular sirolimus product.

Nicotine remains one of the most addictive drugs ever used

Nicotine-the main ingredient in tobacco products-remains one of the most addictive drugs ever used. Still, nearly 72 million people have used nicotine in the United States, according to the 2002 National Survey on Drug Use and Health, which is administered by the Substance Abuse and Mental Health Services Administration (SAMHSA).

Read more Medical News

› Verified 8 days ago

• 1
• 2(current)